Business as usual at PolyMedica.

Yesterday PolyMedica Corporation (NASDAQ: PLMD, $26.62) announced that Stephen C. Farrell was named President of Liberty Healthcare Group to replace W. Keith Trowbridge who resigned effective immediately. Prior to his employment at PolyMedica, Mr. Trowbridge was an officer of Transworld Healthcare, Inc., T2 Medical and Medical Associates of America. Transworld and T2 each faced Medicare fraud allegations and Medical Associates declared bankruptcy after Mr. Trowbridge left. During the five years that Mr. Trowbridge was employed by PolyMedica, quarterly sales grew from $30.6 million to $105.2 million and quarterly EBITDA grew from $4.8 million to $23.4 million. Clearly a lack of generating revenue growth and earnings growth were not the reasons for Mr. Trowbridge’s departure. Our belief is that Mr. Trowbridge’s departure is merely the latest shallow attempt by PolyMedica to appease government prosecutors. We see no reason whatsoever to believe that this latest management change can in any way reduce the magnitude of PolyMedica’s incurred liabilities that result from its alleged criminal conduct. We simply see no ability for PolyMedica to operate profitably without abusing the Medicare system and its beneficiaries.

All of Asensio & Company, Inc.’s reports are covered by the terms and conditions of the mandatory user agreement located at /?page_id=25. The statements below are a part of the user agreement whose entirety is incorporated herein by reference. These statements, and all of the statements contained in the mandatory user agreement, are intended to strictly limit our potential liability to you and your possible legal rights to the fullest extent of the law. Readers are advised to carefully read the entirety of the mandatory user agreement and strictly adhere to the directions given therein.

INVESTMENTS IN SECURITIES, COMMODITIES OR FUTURES HAVE INHERENT RISK, AND A PERSON TAKES SUCH RISKS KNOWINGLY AND BEARS FULL RESPONSIBILITY FOR HIS/HER OWN INVESTMENT RESEARCH AND DECISIONS. Use of this site is at your own risk. None of the information contained herein should be construed as an offer to sell or a solicitation of an offer to buy any securities. In cases where there exists controversy concerning a company’s disclosures, investors should not sell or buy their shares based on the theory that markets price securities efficiently. Furthermore, investors should not rely on the market to substitute for their own individual due diligence and deliberate decision making.

All of the information provided by Asensio & Company, Inc. at asensio.com must be taken as a whole and in its entirety. All of the statements on asensio.com involve, concern and are directed at public issues and public controversies of interest to the public at large. asensio.com contains no statements of fact. All of the statements published by asensio.com constitute written opinions and are not provided to assist any individual or entity in making any investment decision.

Posted in PolyMedica Corporation

Manuel Asensio doesn’t bet often. But when he does, it’s wise to pay attention.

Paul Kaihla
eCompany Now
1 2 3 4 5 6 7 8 9
About Our Founder
Learn more about asensio.com's founder, Manuel P. Asensio, and the website's origins. Click here to be directed to Mr. Asensio’s professional biography.
Media Record
Click here to see selected articles that discuss asensio.com's work and its unique legacy. asensio.com also strives to maintain a complete record of articles dealing with the companies that are the subject of asensio.com research.
Investment Record
Click here to view a list of the companies that have been subjects of asensio.com reporting and click here to see the complete investment record.
Asensio and FINRA
Asensio & Company, Inc. and Manuel P. Asensio are the only dedicated short sellers ever to have been members of FINRA. This unique-minority membership created complications in the regulatory relationship. Being the first activist short investors and among the first FINRA member firms with a website added to the complexity. A statement by Mr. Asensio is available here. Information necessary to obtain a meaningful understanding of the dispute is available in complete form HERE.